Background: One of the most frequent problems caused by diabetes is the so called painful diabetic neuropathy. This condition can be treated through numerous types of therapy. The purpose of this study was to analyze, as a meta-analysis, different treatments used to alleviate painful diabetic neuropathy, with the aim of generating results that help making decisions when applying such treatments to tackle this pathology.
Methods: A search was conducted in the main databases for Health Sciences, such as PUBMED, Web of Science (WOS), and IME biomedicina (Spanish Medical Reports in Biomedicine), to gather randomized controlled trials about treatments used for painful diabetic neuropathy. The analyzed studies were required to meet the inclusion criteria selected, especially those results related to pain intensity.
Results: Nine randomized controlled trials were chosen. The meta-analysis shows significant positive effects for those treatments based on tapentadol [g: -1.333, 95% CI (-1.594; -1.072), P < 0.05], duloxetine [g: -1.622, 95 % CI (-1.650; -1.594), P < 0.05], pregabalin [g: -0.607, 95% CI (-0.980; -0.325), P < 0.05], and clonidine [g: -0.242, 95 % CI (-0.543; -0.058), P < 0.05].
Conclusions: This meta-analysis indicates the effectiveness of the treatments based on duloxetine, gabapentin and pregabalin, as well as other drugs, such as tapentadol and topic clonidine, whose use is better prescribed in more specific situations. The results provided can help increase the knowledge about the treatment of painful diabetic neuropathy and also in the making of clinical practice guidelines for healthcare professionals.
Keywords: Chronic pain; Diabetes complications; Diabetic neuropathies; Pain; Pain management; Pain unit.
Comparative Efficacy and Safety of Six Antidepressants and Anticonvulsants in Painful Diabetic Neuropathy: A Network Meta-AnalysisN Rudroju et al. Pain Physician 16 (6), E705-14. PMID 24284851. - Meta-AnalysisGabapentin was found to be most efficacious and amitriptyline to be least safe among the treatments included in the study. Gabapentin showed most favorable balance betwee …
The Effect of Pregabalin on Pain-Related Sleep Interference in Diabetic Peripheral Neuropathy or Postherpetic Neuralgia: A Review of Nine Clinical TrialsT Roth et al. Curr Med Res Opin 26 (10), 2411-9. PMID 20812792. - ReviewIn addition to an analgesic benefit, pregabalin may decrease pain-related sleep interference in patients with painful diabetic peripheral neuropathy and postherpetic neur …
A Cost-Utility Comparison of Four First-Line Medications in Painful Diabetic NeuropathyAB O'Connor et al. Pharmacoeconomics 26 (12), 1045-64. PMID 19014205.Desipramine (100 mg/day) and duloxetine (60 mg/day) appear to be more cost effective than gabapentin or pregabalin for treating painful diabetic neuropathy. The estimated …
Duloxetine for the Treatment of Painful Diabetic Peripheral Neuropathy in Venezuela: Economic EvaluationF Carlos et al. Medwave 15 (8), e6265. PMID 26460688.This study suggests duloxetine dominates (i.e., is more effective and lead to gains in quality-adjusted life years), remaining less costly than pregabalin for treatment o …
Burning Through the Pain: Treatments for Diabetic NeuropathyS Javed et al. Diabetes Obes Metab 17 (12), 1115-25. PMID 26179288. - ReviewThe rise in the global burden of diabetes is spurring an increase in the prevalence of its complications. Diabetic peripheral neuropathy (DPN) is a common and devastating …
Cited by 1 PubMed Central articles
Perioperative Duloxetine as Part of a Multimodal Analgesia Regime Reduces Postoperative Pain in Lumbar Canal Stenosis Surgery: A Randomized, Triple Blind, and Placebo-Controlled TrialN Govil et al. Korean J Pain 33 (1), 40-47. PMID 31888316.Duloxetine reduces postoperative pain after lumbar canal stenosis surgery with no increase in adverse effects.
- Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. - PubMed
- Asociación Española de Enfermería Vascular y Heridas (AEEVH) Guía de práctica clínica: consenso sobre úlceras vasculares y pie diabético. Segunda edición. Seville: Asociación Española de Enfermería Vascular y Heridas; 2014. pp. 1–90.
- Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956–962. - PubMed
- Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113–1123. e67–e88. - PubMed
- Stein C, Eibel B, Sbruzzi G, Lago PD, Plentz RD. Electrical stimulation and electromagnetic field use in patients with diabetic neuropathy: systematic review and meta-analysis. Braz J Phys Ther. 2013;17:93–104. - PubMed